An Open Trial of Metacognitive Remediation Therapy and Pharmacotherapy to Promote Smoking Cessation among Individuals with Psychotic-Spectrum Disorders
Table 5
Smoking-related outcomes.
Measure
(%)
At least one quit attempt during study period
38 (79.2%)
Confirmed abstinence (per CO levels and self-report)